Treatment of Postpartum Depression with Gender Disappointment

Introduction to Treatment

The American College of Obstetricians and Gynecologists recommends initiating sertraline 25-50 mg daily combined with cognitive behavioral therapy immediately for a new mother with a history of depression experiencing gender disappointment and worsening postpartum symptoms, as untreated depression significantly harms both maternal wellbeing and infant development 1, 2

The Edinburgh Postnatal Depression Scale (EPDS) should be administered to screen for severity and safety concerns, with scores ≥10 indicating depression requiring treatment, and scores ≥13 or significant functional impairment indicating moderate-to-severe depression 3, 2
Direct assessment for suicidal or homicidal ideation should be conducted at every visit, as risk peaks in early treatment, and evaluate functional impairment, inability to perform basic self-care or infant care, which demands immediate psychiatric consultation 2, 3
Thyroid function should be checked, as postpartum thyroiditis affects 5-7% of women and mimics depression, and assess for anemia 2

For moderate-to-severe depression, combination therapy with sertraline 25-50 mg daily and concurrent cognitive behavioral therapy should be started immediately, as combining both modalities decreases clinical morbidity more effectively than either alone 1, 2
Alternative antidepressants, such as paroxetine, fluoxetine, citalopram, or escitalopram, can be used if sertraline is not tolerated, as they are compatible with breastfeeding 2

Postpartum depression frequently co-occurs with anxiety disorders, which gender disappointment may exacerbate, and combined treatment addresses both biological and psychosocial factors 4, 1
A history of depression substantially increases PPD risk, making aggressive treatment essential, and cultural beliefs about gender preference, childbearing, and maternal roles significantly impact postpartum mental health 4, 1
Interventions should be tailored to the patient's cultural context and family structure 1

Reassessment should be conducted at 2-4 weeks after treatment initiation using repeat EPDS scoring, and treatment should continue for 4-12 months minimum for first episode, and indefinitely for recurrent depression 3, 2
Depression prevalence peaks at 12 weeks postpartum and continues rising through the first year, making ongoing surveillance essential, and screen for suicidal ideation at every visit, especially in first months of treatment or with dose changes 3, 2